Rapid Micro (RPID) stock price, chart and financials

Price chart

Revenue (trailing twelve months)

$35.2M

Revenue (quarter)

$8.1M

Revenue growth (year over year)

+10.91%

Gross profit (trailing twelve months)

$2.0M

Gross margin

5.55%

Net income (trailing twelve months)

−$51.2M

Net income (quarter)

−$12.9M

Net income growth (year over year)

−8.98%

Net margin

−145.55%

Return on equity

−141.65%

EPS (trailing twelve months)

−$1.11

Book value per share

$0.36

P/E (trailing twelve months)

—

Price to book

2.47

Debt to assets

69.64%

Payout ratio

—

Dividend yield

—

Company profile

Rapid Micro Biosystems Inc is a life sciences technology company. Its technology uses a sensitive camera and the natural autofluorescence of living cells to identify and quantify microbial growth faster and more accurately than the traditional method, which relies on the human eye. The company develops, manufactures, markets, and sells Growth Direct systems (Systems), proprietary consumables, laboratory information management system (LIMS) connection, and other software and services to address rapid microbial analysis used for quality control in the manufacture of pharmaceuticals, medical devices, and personal care products. Geographically, it generates maximum revenue from the United States, and the rest from Switzerland, Germany, Japan, and all other countries.

• Is Rapid Micro (RPID) profitable?

  No. Rapid Micro reported a net loss of $51.2M over the trailing twelve months.

• How much revenue does Rapid Micro (RPID) make?

  Rapid Micro generated $35.2M in revenue over the trailing twelve months, up 10.91% year over year.

• How do I buy stock in Rapid Micro (RPID)?

  RPID trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at Light Horse Dashboard, the trading API, or an AI agent connected over MCP. The trade panel on this page places the order once you are signed in.